This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Martin PJ, Counts GW Jr, Appelbaum FR, Lee SJ, Sanders JE, Deeg HJ et al. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol 2010; 28: 1011–1016.
Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D et al. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol 2011; 29: 2230–2239.
Atsuta Y, Suzuki R, Yamashita T, Fukuda T, Miyamura K, Taniguchi S et al. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Ann Oncol 2014; 25: 435–441.
Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997; 336: 897–904.
Rizzo JD, Curtis RE, Socie G, Sobocinski KA, Gilbert E, Landgren O et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood 2009; 113: 1175–1183.
Friedman DL, Rovo A, Leisenring W, Locasciulli A, Flowers ME, Tichelli A et al. Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party. Blood 2008; 111: 939–944.
Deeg HJ, Socie G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A et al. Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 1996; 87: 386–392.
Curtis RE, Metayer C, Rizzo JD, Socie G, Sobocinski KA, Flowers ME et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood 2005; 105: 3802–3811.
Cancer Information Service, NCC. Japan Cancer Registry and Statistics. National Cancer Center Hospital, Tokyo, Japan. http://gdb.ganjoho.jp/graph_db/index?changeLang=Submit.
Leisenring W, Friedman DL, Flowers ME, Schwartz JL, Deeg HJ . Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. J Clin Oncol 2006; 24: 1119–1126.
Yokota A, Ozawa S, Masanori T, Akiyama H, Ohshima K, Kanda Y et al. Secondary solid tumors after allogeneic hematopoietic SCT in Japan. Bone Marrow Transplant 2012; 47: 95–100.
Shimada K, Yokozawa T, Atsuta Y, Kohno A, Maruyama F, Yano K et al. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis. Bone Marrow Transplant 2005; 36: 115–121.
Acknowledgements
This work was supported by grants from the National Cancer Research and Development Fund (26-A-26). We thank the medical, nursing, data-processing, laboratory and clinical staff at the National Cancer Center Hospital, Tokyo, Japan, for their important contributions to this study and their dedicated patient care.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Tanaka, Y., Kurosawa, S., Tajima, K. et al. Increased incidence of oral and gastrointestinal secondary cancer after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 52, 789–791 (2017). https://doi.org/10.1038/bmt.2017.4
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2017.4
This article is cited by
-
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update
Bone Marrow Transplantation (2024)
-
Feasibility and usefulness of recommended screenings at long-term follow-up clinics for hematopoietic cell transplant survivors
Supportive Care in Cancer (2022)
-
The risk of malignancies in patients receiving hematopoietic stem cell transplantation: a systematic review and meta-analysis
Clinical and Translational Oncology (2020)
-
Incidence and risk factors of secondary cancers after allogeneic stem cell transplantation: analysis of a single centre cohort with a long follow-up
Bone Marrow Transplantation (2019)